News

  • Dr Tayla Penny researchers a promising early intervention treatment for cerebral palsy in newborn babies at Hudson Institute of Medical Research.

    Early intervention treatment for cerebral palsy shows promise despite sex differences

    A promising early intervention treatment for cerebral palsy in newborn babies has proven effective in both boys and girls – even though it works differently depending on the sex of the offspring.…  Read more

  • Professor Richard Ferrero from the Gastrointestinal Infection and Inflammation Research Group at Hudson Institute

    H.pylori vaccine research targets stomach cancer

    A bacterium present in half the world’s population, Helicobacter pylori  is the target of new research aiming to develop a vaccine against stomach cancer.  …  Read more

  • Associate Professor Michael Gantier, developing RNA therapeutics subject to a new licensing deal, Noxopharm Limited.

    Making more effective and efficient RNA therapeutics

    RNA technology developed by Hudson Institute of Medical Research with the potential to limit inflammatory side-effects of RNA therapeutics such as mRNA vaccines, is the subject of a new licensing deal.…  Read more

  • Professor Suzanne Miller gives newborns with brain injury at birth a better start in life

    Brain injury at birth – a better start for newborns

    Newborn babies who suffer asphyxia at birth could face significantly less risk of disability, thanks to a new treatment developed by Hudson Institute and Monash University scientists.…  Read more

  • Professor Richard Ferrero and Professor Stuart Hooper awarded 2021 NHMRC Ideas Grants

    2021 NHMRC Ideas Grants success

    Hudson Institute has again been recognised in the awarding of NHMRC Ideas Grants. These grants support innovative and creative research and build on Australia’s strong skills and international reputation in advanced health and medical research.…  Read more

  • A/Prof Claudia Nold and Professor Marcel Nold from The Ritchie Centre at Hudson Institute of Medical Research

    Flicking the inflammation off-switch

    Many human diseases, including autoimmune diseases such as arthritis or inflammatory bowel disease, are characterised by too much inflammation.
    There has been a gap in producing new generations of potent anti-inflammatory therapeutics for these anti-inflammatory conditions.…  Read more

  • Dr Shayanti Mukherjee from the Endometrial Stem Cell Biology Research Group at Hudson Institute

    Pelvic organ prolapse treatment attracts international award

    Hudson Institute researcher, Dr Shayanti Mukherjee, has won the prestigious international Women in STEM2D Scholar Award for her ground-breaking bioengineering work in helping women with pelvic organ prolapse (POP). …  Read more

  • Professor Elizabeth Hartland, Director and CEO of Hudson Institute

    Hudson CEO appointed to NHMRC Council

    Hudson Institute has again been recognised as a leader in medical research with our CEO & Director appointed to the Council of the National Health and Medical Research Council (NHMRC).…  Read more

  • Isabella and Lachy having cuddles whilst having treatment in hospital

    Lachy’s story: hope against Stage IV neuroblastoma

    At 18 months, Lachy developed fevers, vomiting and general tiredness. Doctors thought it was a daycare virus and he would get over it. Lachy had an 11 cm tumour in his abdomen and was diagnosed with Stage IV neuroblastoma, which had spread to his bone marrow.…  Read more

  • Dani and Darren holding baby Jack

    Born preterm: Baby Jack’s story

    During his first two months, little Jack endured several setbacks, including having to be put on a ventilator when seizures prevented his breathing.…  Read more

Hudson News

Get the inside view on discoveries and patient stories

Stay connected